Targeting liver cancer stem cell through EpCAM therapy targeted with chemotherapy endorse enhanced progression in hepatocellular carcinoma

被引：0
|
作者：
Vasanthakumar Sekar
Ramakrishnan Veerabathiran
Arjun Pandian
Ganesan Sivamani
机构：
[1] A.V.V.M. Sri Pushpam College,P.G. & Research Department of Zoology & Biotechnology
[2] (Autonomous Institution Affiliated to Bharathidasan University),Human Cytogenetics and Genomics Laboratory, Faculty of Allied Health Sciences
[3] Chettinad Hospital and Research Institute,Department of Biotechnology, Saveetha School of Engineering
[4] Chettinad Academy of Research and Education,undefined
[5] Saveetha Institute of Medical and Technical Sciences (SIMATS) Deemed University,undefined
来源：
Egyptian Liver Journal | / 13卷
关键词：
Cancer stem cell; EpCAM; Hepatocellular; Wnt-β catenin; XAV939;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Targeting liver cancer stem cell through EpCAM therapy targeted with chemotherapy endorse enhanced progression in hepatocellular carcinoma
    Sekar, Vasanthakumar
    Veerabathiran, Ramakrishnan
    Pandian, Arjun
    Sivamani, Ganesan
    EGYPTIAN LIVER JOURNAL, 2023, 13 (01)
  • [2] A preclinical study of EpCAM-targeted therapy for human hepatocellular carcinoma with stem cell features
    Tanaka, Shinji
    Ogawa, Kousuke
    Matsumura, Satoshi
    Aihara, Arihiro
    Ban, Daisuke
    Ochiai, Takanori
    Irie, Takumi
    Kudo, Atsushi
    Arii, Shigeki
    Tanabe, Minoru
    HEPATOLOGY, 2014, 60 : 857A - 857A
  • [3] Preclinical studies of EpCAM-targeted therapy for human hepatocellular carcinoma with specific inhibition of stem cell features
    Tanaka, Shinji
    Ogawa, Kousuke
    Murakata, Ayano
    Mogushi, Kaoru
    Matsumura, Satoshi
    Aihara, Arihiro
    Ban, Daisuke
    Ochiai, Takanori
    Irie, Takumi
    Kudo, Atsushi
    Nakamura, Noriaki
    Tanaka, Hiroshi
    Arii, Shigeki
    Tanabe, Minoru
    CANCER RESEARCH, 2014, 74 (19)
  • [4] Targeting liver cancer stem cells for the treatment of hepatocellular carcinoma
    Li, Na
    Zhu, Ying
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2019, 12
  • [5] Targeting PRKDC activates the efficacy of antitumor immunity while sensitizing to chemotherapy and targeted therapy in liver hepatocellular carcinoma
    Pan, Yitong
    Zhu, Qiyao
    Hong, Ting
    Cheng, Jun
    Tang, Xinhui
    AGING-US, 2024, 16 (10): : 9047 - 9071
  • [6] Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM
    Zhenling Deng
    Yanhong Wu
    Wenbo Ma
    Shuren Zhang
    Yu-Qian Zhang
    BMC Immunology, 16
  • [7] Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM
    Deng, Zhenling
    Wu, Yanhong
    Ma, Wenbo
    Zhang, Shuren
    Zhang, Yu-Qian
    BMC IMMUNOLOGY, 2015, 16
  • [8] Defeating EpCAM+ liver cancer stem cells by targeting chromatin remodeling enzyme CHD4 in human hepatocellular carcinoma
    Nio, Kouki
    Yamashita, Taro
    Okada, Hikari
    Kondo, Mitsumasa
    Hayashi, Takehiro
    Hara, Yasumasa
    Nomura, Yoshimoto
    Zeng, Sha Sha
    Yoshida, Mariko
    Hayashi, Tomoyuki
    Sunagozaka, Hajime
    Oishi, Naoki
    Honda, Masao
    Kaneko, Shuichi
    JOURNAL OF HEPATOLOGY, 2015, 63 (05) : 1164 - 1172
  • [9] DISTINCT LIVER CANCER STEM CELLS DEFINED BY EPCAM AND CD90 IN HUMAN HEPATOCELLULAR CARCINOMA
    Yamashita, Taro
    Honda, Masao
    Nakamoto, Yasunari
    Mizukoshi, Eishiro
    Yamashita, Tatsuya
    Arai, Kuniaki
    Nio, Kouki
    Hara, Yasumasa
    Wang, Xin W.
    Kaneko, Shuichi
    HEPATOLOGY, 2011, 54 : 449A - 449A
  • [10] Hepatocellular carcinoma: from hepatocyte to liver cancer stem cell
    Karakasiliotis, Ioannis
    Mavromara, Penelope
    FRONTIERS IN PHYSIOLOGY, 2015, 6
12345